This topic contains a solution. Click here to go to the answer

Author Question: What was the Supreme Court's decision on this issue?[br][br][b][color=#FA1639]Question ... (Read 72 times)

asmith134

  • Hero Member
  • *****
  • Posts: 576
What was the Supreme Court's decision on this issue?

Question 2

What is the issue before the Supreme Court?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

milbourne11

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

The Supreme Court decided that the Board did not have the power to require the company to agree to a specific collective bargaining demand. The Court stated that allowing the Board to compel agreement when the parties themselves are unable to agree would violate the fundamental premise on which the Act is basedprivate bargaining under governmental supervision of the procedure alone, without any official compulsion over the actual terms of the contract Section 8(d). The Court added that if the Board's remedial powers were insufficient to cope with important labor problems, it was Congress' job, not the Board's or the Courts', to rectify the situation.

Answer to Question 2

The issue before the Court is whether the Board, under the circumstances outlined in Answer 1, had the power to remedy the unfair labor practice by requiring the company to agree to check off the dues of the workers.




asmith134

  • Member
  • Posts: 576
Reply 2 on: Jun 24, 2018
Wow, this really help


ricroger

  • Member
  • Posts: 352
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

Drug-induced pharmacodynamic effects manifested in older adults include drug-induced renal toxicity, which can be a major factor when these adults are experiencing other kidney problems.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

People about to have surgery must tell their health care providers about all supplements they take.

For a complete list of videos, visit our video library